San Francisco Bay Area biotech stories.
Wednesday, November 10, 2010
Corcept Therapeutics loses $7.1M in Q3
Corcept Therapeutics Inc. lost $7.1 million in the September quarter, where a year ago it lost $4.7 million.
The Menlo Park company (NASDAQ: CORT) had no revenue in either quarter.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)